Growth Metrics

Kiniksa Pharmaceuticals International (KNSA) Goodwill & Intangibles (2021 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Goodwill & Intangibles readings, the most recent being $15.0 million for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 6.25% to $15.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.0 million, a 6.25% decrease, with the full-year FY2025 number at $15.2 million, down 23.75% from a year prior.
  • Goodwill & Intangibles hit $15.0 million in Q1 2026 for Kiniksa Pharmaceuticals International, down from $15.2 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $20.0 million in Q1 2022 to a low of $15.0 million in Q1 2026.
  • Median Goodwill & Intangibles over the past 5 years was $17.2 million (2023), compared with a mean of $17.8 million.
  • Biggest five-year swings in Goodwill & Intangibles: increased 15.94% in 2024 and later dropped 23.75% in 2025.
  • Kiniksa Pharmaceuticals International's Goodwill & Intangibles stood at $20.0 million in 2022, then dropped by 13.75% to $17.2 million in 2023, then grew by 15.94% to $20.0 million in 2024, then dropped by 23.75% to $15.2 million in 2025, then fell by 1.64% to $15.0 million in 2026.
  • The last three reported values for Goodwill & Intangibles were $15.0 million (Q1 2026), $15.2 million (Q4 2025), and $15.5 million (Q3 2025) per Business Quant data.